Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Chem Phys ; 160(12)2024 Mar 28.
Article in English | MEDLINE | ID: mdl-38545949

ABSTRACT

Structure determination is necessary to identify unknown organic molecules, such as those in natural products, forensic samples, the interstellar medium, and laboratory syntheses. Rotational spectroscopy enables structure determination by providing accurate 3D information about small organic molecules via their moments of inertia. Using these moments, Kraitchman analysis determines isotopic substitution coordinates, which are the unsigned |x|, |y|, |z| coordinates of all atoms with natural isotopic abundance, including carbon, nitrogen, and oxygen. While unsigned substitution coordinates can verify guesses of structures, the missing +/- signs make it challenging to determine the actual structure from the substitution coordinates alone. To tackle this inverse problem, we develop Kreed (Kraitchman REflection-Equivariant Diffusion), a generative diffusion model that infers a molecule's complete 3D structure from only its molecular formula, moments of inertia, and unsigned substitution coordinates of heavy atoms. Kreed's top-1 predictions identify the correct 3D structure with near-perfect accuracy on large simulated datasets when provided with substitution coordinates of all heavy atoms with natural isotopic abundance. Accuracy decreases as fewer substitution coordinates are provided, but is retained for smaller molecules. On a test set of experimentally measured substitution coordinates gathered from the literature, Kreed predicts the correct all-atom 3D structure in 25 of 33 cases, demonstrating experimental potential for de novo 3D structure determination with rotational spectroscopy.

2.
J Cardiovasc Electrophysiol ; 34(3): 575-582, 2023 03.
Article in English | MEDLINE | ID: mdl-36511474

ABSTRACT

INTRODUCTION: Patients with HIV infection have increased risk of atrial fibrillation, but the pathophysiologic mechanisms and the utility of catheter ablation in this population are not well-studied. We aimed to characterize outcomes of atrial fibrillation ablation and left atrial substrate in patients with HIV. METHODS: The study was a retrospective propensity score-matched analysis of patients with and without HIV undergoing atrial fibrillation ablation. A search was performed in the electronic medical record for all patients with HIV who received initial atrial fibrillation ablation from 2011 to 2020. After calculating propensity scores for HIV, matching was performed with patients without HIV by using nearest-neighbor matching without replacement in a 1:2 ratio. The primary outcome was freedom from atrial arrhythmia and secondary outcomes were freedom from atrial fibrillation, freedom from atrial tachycardia, and freedom from repeat ablation, compared by log-rank analysis. The procedures of patients with HIV who underwent repeat ablation at our institution were further analyzed for etiology of recurrence. To further characterize the left atrial substrate, a subsequent case-control analysis was then performed for a set of randomly chosen 10 patients with HIV matched with 10 without HIV to compare minimum and maximum voltage at nine pre-specified regions of the left atrium. RESULTS: Twenty-seven patients with HIV were identified. All were prescribed antiretroviral therapy at time of ablation. These patients were matched with 54 patients without HIV by propensity score. 86.4% of patients with HIV and 76.9% of controls were free of atrial fibrillation or atrial tachycardia at 1 year (p = .509). Log-rank analysis showed no difference in freedom from atrial arrhythmia (p value .971), atrial fibrillation (p-value .346), atrial tachycardia (p value .306), or repeat ablation (p value .401) after initial atrial fibrillation ablation in patients with HIV compared to patients without HIV. In patients with HIV with recurrent atrial fibrillation, the majority had pulmonary vein reconnection (67%). There were no significant differences in minimum or maximum voltage at any of the nine left atrial regions between the matched patients with and without HIV. CONCLUSIONS: Ablation to treat atrial fibrillation in patients with HIV, but without overt AIDS is frequently successful therapy. The majority of patients with recurrence of atrial fibrillation had pulmonary vein reconnection, suggesting infrequent nonpulmonary vein substrate. In this population, the left atrial voltage in patients with HIV is similar to that of patients without HIV. These findings suggest that the pulmonary veins remain a critical component to the initiation and maintenance of atrial fibrillation in patients with HIV.


Subject(s)
Atrial Fibrillation , Catheter Ablation , HIV Infections , Pulmonary Veins , Tachycardia, Supraventricular , Humans , Atrial Fibrillation/surgery , Retrospective Studies , HIV Infections/complications , HIV Infections/surgery , Treatment Outcome , Heart Atria , Pulmonary Veins/surgery , Catheter Ablation/adverse effects , Recurrence
3.
Phys Rev Lett ; 127(25): 257701, 2021 Dec 17.
Article in English | MEDLINE | ID: mdl-35029442

ABSTRACT

We have measured Coulomb drag between an individual single-walled carbon nanotube (SWNT) as a one-dimensional (1D) conductor and the two-dimensional (2D) conductor monolayer graphene, separated by a few-atom-thick boron nitride layer. The graphene carrier density is tuned across the charge neutrality point (CNP) by a gate, while the SWNT remains degenerate. At high temperatures, the drag resistance changes sign across the CNP, as expected for momentum transfer from drive to drag layer, and exhibits layer exchange Onsager reciprocity. We find that layer reciprocity is broken near the graphene CNP at low temperatures due to nonlinear drag response associated with temperature dependent drag and thermoelectric effects. The drag resistance shows power-law dependences on temperature and carrier density characteristic of 1D Fermi liquid-2D Dirac fluid drag. The 2D drag signal at high temperatures decays with distance from the 1D source slower than expected for a diffusive current distribution, suggesting additional interaction effects in the graphene in the hydrodynamic transport regime.

4.
J Cardiovasc Electrophysiol ; 31(7): 1678-1686, 2020 07.
Article in English | MEDLINE | ID: mdl-32314841

ABSTRACT

INTRODUCTION: Catheter stability during atrial fibrillation ablation is associated with higher ablation success rates. Rapid cardiac pacing and high-frequency jet ventilation (HFJV) independently improve catheter stability. Simultaneous modulation of cardiac and respiratory motion has not been previously studied. The objective of this study was to determine the effect of simultaneous heart rate and respiratory rate modulation on catheter stability. METHODS: Forty patients undergoing paroxysmal atrial fibrillation ablation received ablation lesions at 15 prespecified locations (12 left atria, 3 right atria). Patients were randomly assigned to undergo rapid atrial pacing for either the first or the second half of each lesion. Within each group, half of the patients received HFJV and the other half standard ventilation. Contact force and ablation data for all lesions were compared among the study groups. Standard deviation of contact force was the primary endpoint defined to examine contact force variability. RESULTS: Lesions with no pacing and standard ventilation had the greatest contact force standard deviation (5.86 ± 3.08 g), compared to lesions with pacing and standard ventilation (5.45 ± 3.28 g; P < .01) or to lesions with no pacing and HFJV (4.92 ± 3.00 g; P < .01). Lesions with both pacing and HFJV had the greatest reduction in contact force standard deviation (4.35 ± 2.81 g; P < .01), confirming an additive benefit of each maneuver. Pacing and HFJV together was also associated with a reduction in the proportion of lesions with excessive maximum contact force (P < .001). DISCUSSION: Rapid pacing and HFJV additively improve catheter stability. Simultaneous pacing with HFJV further improves catheter stability over pacing or HFJV alone to optimize ablation lesions.


Subject(s)
Atrial Fibrillation , Catheter Ablation , High-Frequency Jet Ventilation , Atrial Fibrillation/diagnosis , Atrial Fibrillation/surgery , Catheters , Heart Atria/diagnostic imaging , Heart Atria/surgery , Humans
5.
Phys Rev Lett ; 123(21): 216804, 2019 Nov 22.
Article in English | MEDLINE | ID: mdl-31809158

ABSTRACT

Relativistic massless charged particles in a two-dimensional conductor can be guided by a one-dimensional electrostatic potential, in an analogous manner to light guided by an optical fiber. We use a carbon nanotube to generate such a guiding potential in graphene and create a single mode electronic waveguide. The nanotube and graphene are separated by a few nanometers and can be controlled and measured independently. As we charge the nanotube, we observe the formation of a single guided mode in graphene that we detect using the same nanotube as a probe. This single electronic guided mode in graphene is sufficiently isolated from other electronic states of linear Dirac spectrum continuum, allowing the transmission of information with minimal distortion.

6.
Stem Cells ; 33(4): 1200-12, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25532725

ABSTRACT

The use of bone marrow-derived mesenchymal stromal cells (BMSC) in the treatment of alloimmune and autoimmune conditions has generated much interest, yet an understanding of the therapeutic mechanism remains elusive. We therefore explored immune modulation by a clinical-grade BMSC product in a model of human-into-mouse xenogeneic graft-versus-host disease (x-GVHD) mediated by human CD4(+) Th1 cells. BMSC reversed established, lethal x-GVHD through marked inhibition of Th1 cell effector function. Gene marking studies indicated BMSC engraftment was limited to the lung; furthermore, there was no increase in regulatory T cells, thereby suggesting a paracrine mechanism of BMSC action. BMSC recipients had increased serum CD73 expressing exosomes that promoted adenosine accumulation ex vivo. Importantly, immune modulation mediated by BMSC was fully abrogated by pharmacologic therapy with an adenosine A2A receptor antagonist. To investigate the potential clinical relevance of these mechanistic findings, patient serum samples collected pre- and post-BMSC treatment were studied for exosome content: CD73 expressing exosomes promoting adenosine accumulation were detected in post-BMSC samples. In conclusion, BMSC effectively modulate experimental GVHD through a paracrine mechanism that promotes adenosine-based immune suppression.


Subject(s)
Adenosine A2 Receptor Antagonists/pharmacology , Mesenchymal Stem Cells/immunology , Signal Transduction/immunology , Th1 Cells/immunology , Animals , Bone Marrow/drug effects , Bone Marrow/immunology , Coculture Techniques , Graft vs Host Disease/immunology , Humans , Mesenchymal Stem Cells/drug effects , Mice , Mice, Inbred NOD , Mice, SCID , Signal Transduction/drug effects , Th1 Cells/drug effects
7.
JACC Clin Electrophysiol ; 5(5): 626-634, 2019 05.
Article in English | MEDLINE | ID: mdl-31122386

ABSTRACT

OBJECTIVES: This study sought to determine whether a radiation safety time-out reduces radiation exposure in electrophysiology procedures. BACKGROUND: Time-outs are integral to improving quality and safety. The authors hypothesized that a radiation safety time-out would reduce radiation exposure levels for patients and the health care team members. METHODS: The study was performed at the New York University Langone Health Electrophysiology Lab. Baseline data were collected for 6 months prior to the time-out. On implementation of the time-out, data were collected prospectively with analyses to be performed every 3 months. The primary endpoint was dose area product. The secondary endpoints included reference point dose, fluoroscopy time, use of additional shielding, and use of alternative imaging such as intracardiac and intravascular ultrasound. RESULTS: A total of 1,040 patient cases were included. The median dose area product prior to time-out was 18.7 Gy∙cm2, and the median during the time-out was 14.7 Gy∙cm2, representing a 21% reduction (p = 0.007). The median reference point dose prior to time-out was 163 mGy, and during the time-out was 122 mGy (p = 0.011). The use of sterile disposable protective shields and ultrasound imaging for access increased significantly during the time-out. CONCLUSIONS: A radiation safety time-out significantly reduces radiation exposure in electrophysiology procedures. Electrophysiology laboratories, as well as other areas of cardiovascular medicine using fluoroscopy, should strongly consider the use of radiation safety time-outs to reduce radiation exposure and improve safety.


Subject(s)
Electrophysiologic Techniques, Cardiac , Patient Safety , Radiation Dosage , Radiation Exposure , Aged , Aged, 80 and over , Electrophysiologic Techniques, Cardiac/methods , Electrophysiologic Techniques, Cardiac/standards , Female , Fluoroscopy/standards , Humans , Male , Prospective Studies , Radiation Exposure/prevention & control , Radiation Exposure/standards , Radiation Exposure/statistics & numerical data , Time Factors
8.
JACC Clin Electrophysiol ; 4(4): 483-490, 2018 04.
Article in English | MEDLINE | ID: mdl-30067488

ABSTRACT

OBJECTIVES: This study sought to investigate the effect of pacing mediated heart rate modulation on catheter-tissue contact and impedance reduction during radiofrequency ablation in human atria during atrial fibrillation (AF) ablation. BACKGROUND: In AF ablation, improved catheter-tissue contact enhances lesion quality and acute pulmonary vein isolation rates. Previous studies demonstrate that catheter-tissue contact varies with ventricular contraction. The authors investigated the impact of modulating heart rate on the consistency of catheter-tissue contact and its effect on lesion quality. METHODS: Twenty patients undergoing paroxysmal AF ablation received ablation lesions at 15 pre-specified locations (12 left atria, 3 right atria). Patients were assigned randomly to undergo rapid atrial pacing for either the first half or the second half of each lesion. Contact force and ablation data with and without pacing were compared for each of the 300 ablation lesions. RESULTS: Compared with lesion delivery without pacing, pacing resulted in reduced contact force variability, as measured by contact force SD, range, maximum, minimum, and time within the pre-specified goal contact force range (p < 0.05). There was no difference in the mean contact force or force-time integral. Reduced contact force variability was associated with a 30% greater decrease in tissue impedance during ablation (p < 0.001). CONCLUSIONS: Pacing induced heart rate acceleration reduces catheter-tissue contact variability, increases the probability of achieving pre-specified catheter-tissue contact endpoints, and enhances impedance reduction during ablation. Modulating heart rate to improve catheter-tissue contact offers a new approach to optimize lesion quality in AF ablation. (The Physiological Effects of Pacing on Catheter Ablation Procedures to Treat Atrial Fibrillation [PEP AF]; NCT02766712).


Subject(s)
Atrial Fibrillation/surgery , Cardiac Pacing, Artificial/methods , Catheter Ablation/methods , Heart Atria/surgery , Heart Rate/physiology , Female , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL